Core Insights - The Zhangjiang Pharmaceutical Valley Global Promotion Conference and International Innovation Conference aims to enhance the global competitiveness of the biopharmaceutical industry in Pudong, Shanghai [1] - Pudong has achieved a biopharmaceutical industry scale of 220 billion yuan in the first half of the year, with an annual compound growth rate of 14%, and is expected to exceed 440 billion yuan for the entire year [1] - The newly released "Implementation Plan for Promoting the Full-Chain Development of High-End Medical Device Industry (2025-2027)" outlines measures to create a globally influential medical device industry system [1][2] Industry Development - The biopharmaceutical industry is one of Shanghai's three leading industries and is a focal point of the new technological revolution and competition [1] - Pudong has gathered 750 foreign-funded biopharmaceutical companies, becoming a strategic hub for global biopharmaceutical innovation and cooperation [1] - The medical device sector in Pudong includes 468 research and production enterprises, with 16 of the top 20 global companies established in the area [2] Innovation Achievements - Zhangjiang Pharmaceutical Valley has approved 29 Class 1 domestic new drugs, with 7 innovative drugs expected to be launched in 2025, showcasing strong source innovation capabilities [3] - In the field of innovative medical devices, 38 products have been approved, with 4 launched in 2025, filling domestic technological gaps [3] - The establishment of the Zhangjiang Pharmaceutical Valley Comprehensive Service Center aims to provide a full lifecycle service for enterprises, enhancing the service capabilities of the industry [3] Expert Support - The Pudong New Area Biopharmaceutical Industry Development Expert Committee has appointed new experts to provide intellectual support for technology layout, innovation ecosystem construction, and industrial policy formulation [4]